Ganirelix Acetate
NDC 65219-028, Ganirelix Acetate, injection, from Fresenius Kabi USA, LLC.
- Product NDC
- 65219-028
- Status
- Listed
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215658
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65219-028 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GANIRELIX ACETATE250 ug/.5mL
Pharmacologic classes
Decreased GnRH Secretion [PE]; Gonadotropin Releasing Hormone Receptor Antagonist [EPC]; Gonadotropin Releasing Hormone Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65219-028-05 | 65219002805 | 1 SYRINGE, GLASS in 1 CARTON (65219-028-05) / 1 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/c23ca7b2-7350-4f07-8adf-046bffb47842NADAC price for package 65219002805
GET /v1/drugs/nadac/65219002805
Use it
Look up 65219-028 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65219-028 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65219-028. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.